High molecular weight constituents of cranberry interfere with influenza virus neuraminidase activity in vitro

Planta Medica

Volumn 78, Issue 10, 2012, Pages 962-967

  Oiknine Djian, Esther ^a   Houri Haddad, Yael ^b   Weiss, Ervinitshak ^b   Ofek, Itzhak ^c   Greenbaum, Evguenia ^a   Hartshorn, Kevan ^d   Zakay Rones, Zichria ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cranberry juice; Ericaceae; influenza virus; NDM; neuraminidase; Vaccinium macrocarpon Ait

Indexed keywords

CRANBERRY EXTRACT; INFLUENZA VIRUS HEMAGGLUTININ; NON DIALYZABLE MATERIAL; OSELTAMIVIR; UNCLASSIFIED DRUG; VIRUS SIALIDASE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; CRANBERRY JUICE; CYTOPATHOGENIC EFFECT; DRUG POTENCY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HEMAGGLUTINATION INHIBITION TEST; IC 50; IN VITRO STUDY; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MOLECULAR WEIGHT; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; VIRUS REPLICATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CELL LINE; DOGS; DRUG EVALUATION, PRECLINICAL; ENZYME ACTIVATION; ENZYME INHIBITORS; ERYTHROCYTES; HEMAGGLUTINATION TESTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MOLECULAR WEIGHT; NEURAMINIDASE; PLANT EXTRACTS; STREPTOCOCCUS; VACCINIUM MACROCARPON; VIRAL PROTEINS; VIRUS CULTIVATION;

BACTERIA (MICROORGANISMS); ERICACEAE; ORTHOMYXOVIRIDAE; STREPTOCOCCUS PNEUMONIAE; VACCINIUM MACROCARPON;

EID: 84863572275     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0031-1298579     Document Type: Article

References (35)

1. Zakay-Rones Z. Human influenza vaccines and assessment of immunogenicity. Expert Rev Vaccines: 2010; 9 1423 1439
2. Monto AS. The role of antivirals in the control of influenza. Vaccine: 2003; 21 1796 1800 (Pubitemid 36398376)
3. Suzuki H, Saito R, Masuda H, Oshitani H, Sato M, Sato I. Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother: 2003; 9 195 200 (Pubitemid 37288281)
4. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y. Avian flu: isolation of drug-resistant H5N1 virus. Nature: 2005; 437 1108 (Pubitemid 41509341)
5. Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van t Veen A, van der Vries E, te Wierik M, Koopmans M. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antiviral Res: 2011; 92 81 89
6. Mochalova L, Bright R, Xu X, Korchagina E, Chinarev A, Bovin N, Klimov A. Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors. Glycoconj J: 2010; 27 321 327
7. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, Kobasa D, Kawaoka Y. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol: 2000; 74 6015 6020 (Pubitemid 30412971)
8. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol: 2004; 78 12665 12667 (Pubitemid 39458784)
9. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine: 2007; 25 2842 2851 (Pubitemid 46412567)
10. Shmuely H, Ofek I, Weiss EI, Rones Z, Houri-Haddad Y. Cranberry components for the therapy of infectious disease. Curr Opin Biotechnol: 2012; 23 148 152
11. Weiss EI, Houri-Haddad Y, Greenbaum E, Hochman N, Ofek I, Zakay-Rones Z. Cranberry juice constituents affect influenza virus adhesion and infectivity. Antiviral Res: 2005; 66 9 12 (Pubitemid 40386698)
12. Lipson SM, Sethi L, Cohen P, Gordon RE, Tan IP, Burdowski A, Stotzky G. Antiviral effects on bacteriophages and rotavirus by cranberry juice. Phytomedicine: 2007; 14 23 30 (Pubitemid 44960810)
13. De Bruyne T, Pieters L, Witvrouw M, De Clercq E, Vanden Berghe D, Vlietinck AJ. Biological evaluation of proanthocyanidin dimers and related polyphenols. J Nat Prod: 1999; 62 954 958 (Pubitemid 29357439)
14. Zakay-Rones Z, Thom E, Wollan T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res: 2004; 32 132 140 (Pubitemid 38401079)
15. Liu AL, Liu B, Qin HL, Lee SM, Wang YT, Du GH. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med: 2008; 74 847 851 (Pubitemid 351991120)
16. Bodet C, Grenier D, Chandad F, Ofek I, Steinberg D, Weiss EI. Potential oral health benefits of cranberry. Crit Rev Food Sci Nutr: 2008; 48 672 680
17. Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N. Anti- Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med: 1991; 324 1599
18. Labrecque J, Bodet C, Chandad F, Grenier D. Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother: 2006; 58 439 443 (Pubitemid 44294962)
19. Bodet C, Chandad F, Grenier D. Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res: 2006; 85 235 239 (Pubitemid 43827731)
20. Cohen-Daniel L, Zakay-Rones Z, Resnick IB, Shapira MY, Dorozhko M, Mador N, Greenbaum E, Wolf DG. Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient. J Clin Virol: 2009; 44 138 140
21. Hartley CA, Reading PC, Ward AC, Anders EM. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch Virol: 1997; 142 75 88 (Pubitemid 27050433)
22. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N- acetylneuraminate) substrate. Anal Biochem: 1979; 94 287 296 (Pubitemid 9173017)
23. Tecle T, White MR, Crouch EC, Hartshorn KL. Inhibition of influenza viral neuraminidase activity by collectins. Arch Virol: 2007; 152 1731 1742 (Pubitemid 47319266)
24. Hament JM, Kimpen JL, Fleer A, Wolfs TF. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol: 1999; 26 189 195
25. Hartshorn KL, Liou LS, White MR, Kazhdan MM, Tauber JL, Tauber AI. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol: 1995; 154 3952 3960
26. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis: 2003; 187 1000 1009 (Pubitemid 36337913)
27. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis: 2002; 186 341 350 (Pubitemid 34816317)
28. Tashiro M, Beppu Y, Sakai K, Kido H. Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs. Arch Virol: 1996; 141 1571 1577 (Pubitemid 26351185)
29. Dalia AB, Standish AJ, Weiser JN. Three surface exoglycosidases from Streptococcus pneumoniae, NanA, BgaA, and StrH, promote resistance to opsonophagocytic killing by human neutrophils. Infect Immun: 2010; 78 2108 2116
30. Gubareva LV, Webster RG, Hayden FG. Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res: 2002; 53 47 61 (Pubitemid 33001554)
31. Chen Z, Aspelund A, Jin H. Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs. Vaccine: 2008; 26 361 371
32. Saito T, Nakaya Y, Suzuki T, Ito R, Saito H, Takao S, Sahara K, Odagiri T, Murata T, Usui T, Suzuki Y, Tashiro M. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J Med Virol: 2004; 74 336 343 (Pubitemid 39150402)
33. Gamblin SJ, Skehel JJ. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem: 2010; 285 28403 28409
34. Malaisree M, Rungrotmongkol T, Decha P, Intharathep P, Aruksakunwong O, Hannongbua S. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1. Proteins: 2008; 71 1908 1918 (Pubitemid 351732944)
35. von Itzstein M. The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov: 2007; 6 967 974